IFF Earnings Date: Nov 3, 2026 (Estimated) — International Flavors & Fragrances Inc.
NYSE · Materials · Specialty Chemicals
Updated
When is IFF's next earnings date?
International Flavors & Fragrances Inc. (IFF) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.81 on revenue of $1.91B.
How did IFF do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), International Flavors & Fragrances Inc. posted EPS of $0.82 versus the $1.07 estimate, a miss of 26.8%. Revenue was $1.95B against a $2.62B estimate. The stock's 1-day post-earnings move was +8.9%.
How much does IFF stock move after earnings?
IFF beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.7% (up or down) in the day after earnings.
About International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | 1.07 | 0.82 | -26.79% | $1.95B | ❌ Miss | +8.88% | +5.08% | +7.48% |
| 2026-05-05 | Q1 2026 | 1.07 | 1.25 | +16.82% | $2.74B | ✅ Beat | +17.18% | +10.87% | +3.47% |
| 2026-02-11 | Q4 2025 | 0.84 | 0.80 | -4.76% | $2.59B | ❌ Miss | +5.89% | +6.03% | -9.57% |
| 2025-11-04 | Q3 2025 | 1.02 | 1.05 | +2.94% | $2.69B | ✅ Beat | +4.09% | +6.22% | +8.13% |
| 2025-08-05 | Q2 2025 | 1.12 | 1.15 | +2.68% | $2.76B | ✅ Beat | -6.32% | -8.61% | -7.21% |
| 2025-02-18 | Q4 2024 | 0.82 | 0.97 | +18.29% | $2.77B | ✅ Beat | -5.16% | -7.13% | -6.82% |
| 2024-11-05 | Q3 2024 | 1.08 | 1.04 | -3.70% | $2.92B | ❌ Miss | -11.63% | -9.75% | -10.18% |
| 2024-08-06 | Q2 2024 | 1.00 | 1.16 | +16.00% | $2.89B | ✅ Beat | -2.36% | +0.13% | +6.41% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $1.95B total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Taste | 35.2% | $688.0M | +9.0% | — | $627.0M | $631.0M | $635.0M |
| Scent | 34.0% | $665.0M | +10.3% | $579.0M | $614.0M | $603.0M | $652.0M |
| Health & Biosciences | 30.8% | $601.0M | +4.2% | $453.0M | $540.0M | $577.0M | $577.0M |
By region
Q2 FY26 · $1.95B total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| EMEA | 36.6% | $715.0M | -25.0% | $927.0M | $952.0M | $953.0M | $933.0M |
| Asia | 25.6% | $501.0M | -22.6% | $674.0M | $670.0M | $647.0M | $617.0M |
| North America | 24.6% | $481.0M | -40.1% | $812.0M | $868.0M | $803.0M | $779.0M |
| Latin America | 13.2% | $257.0M | -28.8% | $358.0M | $353.0M | $361.0M | $365.0M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.